Ying Gu Selected Research

Colorectal Neoplasms (Colorectal Cancer)

1/2023	Current progress in the development of prophylactic and therapeutic vaccines.
6/2022	A Novel Proteogenomic Integration Strategy Expands the Breadth of Neo-Epitope Sources.
9/2019	ARHGAP25: A negative regulator of colorectal cancer (CRC) metastasis via the Wnt/β-catenin pathway.
9/2019	Weichang'an suppressed migration and invasion of HCT116 cells by inhibiting Wnt/β-catenin pathway while upregulating ARHGAP25.
1/2015	Weichang'an and 5-fluorouracil suppresses colorectal cancer in a mouse model.
12/2010	[Clinical study on survival benefit for elderly patients with resected stage II or III colorectal cancer based on traditional Chinese medicine syndrome differentiation and treatment].
12/2004	Honokiol: a potent chemotherapy candidate for human colorectal carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ying Gu Research Topics

Disease

64	Neoplasms (Cancer) 02/2024 - 04/2003
25	Port-Wine Stain (Nevus Flammeus) 02/2021 - 06/2007
21	Infections 07/2023 - 12/2003
14	Periodontitis 01/2023 - 03/2010
11	Inflammation (Inflammations) 01/2023 - 12/2011
9	Leukemia 01/2022 - 08/2006
7	COVID-19 11/2023 - 12/2020
7	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 12/2004
7	Virus Diseases (Viral Diseases) 01/2023 - 01/2017
7	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 03/2014
7	Neoplasm Metastasis (Metastasis) 09/2019 - 01/2005
6	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 12/2011
6	Hepatitis E 01/2020 - 01/2004
5	Breast Neoplasms (Breast Cancer) 10/2023 - 01/2005
5	Stomach Neoplasms (Stomach Cancer) 01/2023 - 09/2005
5	Aneuploidy (Aneuploid) 01/2023 - 10/2015
5	Wounds and Injuries (Trauma) 04/2022 - 09/2007
5	Periodontal Diseases (Periodontal Disease) 01/2022 - 12/2011
5	Skin Diseases (Skin Disease) 06/2016 - 03/2010
4	Osteoporosis 01/2024 - 12/2018
4	Hypertension (High Blood Pressure) 01/2023 - 11/2017
4	Pain (Aches) 01/2023 - 06/2014
4	Carcinoma (Carcinomatosis) 11/2017 - 04/2003
3	Gestational Diabetes (Gestational Diabetes Mellitus) 12/2023 - 01/2016
3	Pre-Eclampsia (Preeclampsia) 05/2023 - 11/2017
3	Hyperglycemia 01/2023 - 01/2016
3	Human Influenza (Influenza) 01/2023 - 01/2022
3	Chronic Disease (Chronic Diseases) 01/2023 - 01/2021
3	Heart Failure 01/2022 - 01/2014
3	Alveolar Bone Loss 01/2022 - 01/2019
3	Obesity 12/2021 - 10/2010
3	Hemorrhage 02/2020 - 06/2012
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 05/2007
3	Hyperpigmentation 09/2018 - 09/2011
3	Papillomavirus Infections 01/2017 - 06/2015
3	Vascular Diseases (Vascular Disease) 01/2017 - 03/2009
3	Macular Degeneration (Age-Related Maculopathy) 05/2015 - 04/2010
3	Choroidal Neovascularization 05/2015 - 07/2010
3	Heart Diseases (Heart Disease) 01/2014 - 03/2013
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2012 - 08/2006
2	Intrahepatic Cholestasis of Pregnancy 11/2023 - 01/2023
2	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2023 - 01/2021
2	Shock 07/2023 - 01/2023
2	Necrosis 03/2023 - 12/2004

Drug/Important Bio-Agent (IBA)

37	1-phenyl-3,3-dimethyltriazene (PDT)IBA 10/2023 - 12/2004
25	VaccinesIBA 01/2024 - 01/2005
16	Proteins (Proteins, Gene)FDA Link 04/2024 - 08/2006
11	Photosensitizing Agents (Photosensitizers)IBA 07/2023 - 02/2010
11	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 01/2005
10	Biomarkers (Surrogate Marker)IBA 04/2024 - 12/2003
9	CytokinesIBA 01/2023 - 12/2011
8	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2015
7	CurcuminIBA 01/2023 - 01/2013
7	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 03/2010
7	hematoporphyrin monomethyl etherIBA 09/2018 - 09/2007
6	Neutralizing AntibodiesIBA 11/2023 - 01/2017
6	RNA (Ribonucleic Acid)IBA 07/2023 - 04/2010
6	Peptides (Polypeptides)IBA 01/2023 - 04/2005
5	Oxygen (Dioxygen)IBA 02/2024 - 12/2010
5	1,7- bis(4- hydroxyphenyl)- 4- N- phenylaminocarbonylhepta- 1,6- dien- 3,5- dioneIBA 01/2023 - 01/2016
5	EpitopesIBA 06/2022 - 06/2008
5	AntibodiesIBA 04/2021 - 12/2003
5	CateninsIBA 09/2019 - 11/2012
5	Fluorouracil (Carac)FDA LinkGeneric 11/2017 - 05/2007
4	EnzymesIBA 12/2023 - 07/2012
4	Long Noncoding RNAIBA 05/2023 - 01/2013
4	Interleukin-6 (Interleukin 6)IBA 02/2023 - 12/2011
4	Indicators and Reagents (Reagents)IBA 01/2022 - 06/2011
4	Monoclonal AntibodiesIBA 07/2020 - 10/2015
4	Weichang'anIBA 09/2019 - 09/2005
4	TetracyclinesIBA 06/2016 - 01/2005
4	Doxycycline (Periostat)FDA LinkGeneric 06/2016 - 03/2010
4	Therapeutic UsesIBA 10/2015 - 02/2010
3	Eosine Yellowish-(YS) (Eosin)IBA 07/2023 - 09/2007
3	LipopolysaccharidesIBA 02/2023 - 01/2019
3	Matrix Metalloproteinase InhibitorsIBA 01/2023 - 01/2020
3	AntigensIBA 01/2023 - 04/2021
3	Oncogene Proteins (Oncogene Protein)IBA 10/2021 - 06/2015
3	EndotoxinsIBA 09/2021 - 12/2011
3	Messenger RNA (mRNA)IBA 01/2021 - 11/2012
3	Tetracycline (Achromycin)FDA LinkGeneric 06/2016 - 01/2005
3	hypocrellin BIBA 05/2015 - 03/2012
3	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2014 - 12/2004
3	berbamine (penduline)IBA 12/2012 - 08/2006
3	tetracycline CMT-3IBA 01/2012 - 01/2005
3	Singlet OxygenIBA 09/2011 - 12/2004
3	Immunoglobulin G (IgG)IBA 06/2011 - 12/2003
2	Subunit VaccinesIBA 01/2024 - 01/2023
2	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 01/2022
2	ImmunosorbentsIBA 12/2023 - 12/2020
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2023 - 01/2023
2	Hematoxylin (Haematoxylon)IBA 07/2023 - 01/2015

Therapy/Procedure

37	Therapeutics 11/2023 - 06/2007
35	Photochemotherapy (Photodynamic Therapy) 10/2023 - 09/2007
16	Lasers (Laser) 01/2023 - 06/2007
6	Drug Therapy (Chemotherapy) 07/2020 - 12/2004
5	Immunotherapy 01/2024 - 01/2013
3	Phototherapy (Light Therapy) 01/2023 - 03/2009
3	Aftercare (After-Treatment) 09/2018 - 08/2006
2	Photothermal Therapy 11/2023 - 07/2020